New UK HIV data spur calls for better access to testing
This article was originally published in Clinica
The UK's Health Protection Agency (HPA) is calling for better access to HIV diagnostic testing services, in light of data published today showing that the incidence of infection is at its highest among injecting drug users (IDUs) for over a decade. The HPA's IDU expert, Dr Fortune Ncube, said that it was imperative too that there is sufficient access to needles and syringes, as well as improving advice on safe disposal of used devices.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.